Digital app collects lifestyle and health data for brain inflammation research
Participants share health data and symptoms through an app to study brain inflammation.
Key facts
- Who runs it
- Brain Inflammation Collaborative
- Where
- Delafield, United StatesSee the site
- Trial code
- Registry title
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
- Status
- Recruiting
- People taking part
- 10,000 people, planned
- Started
- 5 Jul 2023
- Expected to end
- 31 Dec 2030
- Type of study
- Observational, 2 groups
- Record updated
- 22 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people in the United States, aged 2 or older, with brain inflammation or related conditions, and also healthy people. Everyone shares health data through an app.
- Age
- 2 years and older
- Sex
- All sexes
- Disease stage
- Conditions named in the record: Long COVID, chronic Lyme, ME/CFS, PANS/PANDAS, migraines, dysautonomia, POTS, multiple sclerosis, autism spectrum disorder, autoimmune diseases, Crohn's Disease, Celiac Disease, ulcerative colitis, and mood or behavioral disorders. Healthy people without brain inflammation can also join. A diagnosis by a doctor or a self-diagnosis is accepted.
Main reasons for not taking part
- Does not live in the United States
- No steady internet access and no phone, tablet or PC
- Cannot take part in English
- Not willing to share symptom and health data through the platform
The registry criteria, word for word
Show all 10 criteriaShow less
Other criteria
- Participants may be either self-diagnosed, or diagnosed by a physician with the following conditions:
- Infection-associated chronic conditions such as Long COVID, chronic Lyme, myalgic encephalomyelitis (ME/CFS), and post-acute neuropsychiatric syndrome (PANS/PANDAS)
- Neuroimmune, developmental, autonomic, and neurological conditions like migraines, dysautonomia, POTS, multiple sclerosis, and autism spectrum disorder
- Autoimmune diseases such as Lupus, Sjogren's Disease, rheumatoid arthritis, myasthenia gravis, ankylosing spondylitis, and related autoimmune conditions; Inflammatory gastrointestinal conditions such as Crohn's Disease, Celiac Disease, and ulcerative colitis
- Behavioral and mood disorders such as anxiety, depression, bipolar disorder, PTSD, eating disorders, OCD, and other related conditions
- "Healthy" people (without brain inflammation), including unaffected individuals, unaffected individuals in the same household, and unaffected individuals who are married to relatives and family members
- Have consistent internet access and a cell phone, tablet, or PC since this is an online or app-based platform that requires entering data and completing surveys
- Currently live in the United States
- Be able to participate in English (stay tuned for updates about the Spanish language version)
- Be willing to share symptom and health data through the platform
Where in United States
- Brain Inflammation CollaborativeDelafield, United StatesContact: Christy Jagdfeld, CPATaking people
About the trial
What the trial wants to find out
The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle information from individuals with brain inflammation and related neuroinflammatory conditions. Participants in the United States aged 2 years and older will provide self-reported health data, biometrics, and symptom diaries through the MyDataHelps™ app (branded as unhide® for this study). The goal is to create comprehensive longitudinal profiles to facilitate research into disease subtypes, causes, diagnostics, and potential treatments, as well as to identify potential participants for future optional studies. "Healthy" individuals without brain inflammation are also eligible to participate.
Read full original descriptionShow less
The digital health research platform used in this study was originally developed and designed by Solve M.E and was called SolveTogether. The Brain Inflammation Collaborative (BIC) expanded upon Solve M.E.'s work to include related diagnoses, pediatric participants, enhance symptom tracking, and more. BIC and Solve M.E. combined Solve Together and unhide®, to create The unhide® Solve Together Unified Platform in 2025.
The 2 groups in the trial
- People with brain inflammation and related neuroinflammatory conditions
No intervention will be administered.
- Healthy Controls
No intervention will be administered.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Unhide® Project Also Known as The Unhide® Solve Together Unified Platform
- Plain-language title
- Digital app collects lifestyle and health data for brain inflammation researchGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Publications
- Record updated
- 22 January 2026